# ARDA Software for the Detection of mtmDR

> **NCT04905459** · — · COMPLETED · sponsor: **Verily Life Sciences LLC** · enrollment: 1012 (actual)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **DIAGNOSTIC_TEST:** ARDA software application

## Key facts

- **NCT ID:** NCT04905459
- **Lead sponsor:** Verily Life Sciences LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-30
- **Primary completion:** 2022-05-23
- **Final completion:** 2022-05-23
- **Target enrollment:** 1012 (ACTUAL)
- **Last updated:** 2022-06-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04905459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04905459, "ARDA Software for the Detection of mtmDR". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04905459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*